Corcept Therapeutics (CORT) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $118.55 +1.18%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q2 EPS of ($0.02), $0.02 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $12 million versus the consensus estimate of $11.67 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Assumes Corcept Therapeutics (CORT) at Buy
- GLJ Research on Sell Rated Tesla (TSLA): 'We now see FSD as the main reason TSLA’s stock will bleed lower this year'
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
